Skip to main content
CAMBIUM BIO LIMITED logo

CAMBIUM BIO LIMITED — Investor Relations & Filings

Ticker · CMB ISIN · AU0000327769 ASX Professional, scientific and technical activities
Open in API
Filings indexed 504 across all filing types
Latest filing 2019-10-29 Annual Report
Country AU Australia
Listing ASX CMB

About CAMBIUM BIO LIMITED

https://www.cambium.bio

Cambium Bio Limited is a clinical-stage regenerative medicine company focused on developing innovative cellular therapies to treat unmet medical needs in ophthalmology and inflammatory diseases. The company's primary focus is on its lead candidate, EluRegen, a first-in-class topical biologic designed for the treatment of corneal epithelial defects and dry eye disease. Utilizing its proprietary technology platforms, the company aims to harness the regenerative potential of biologics to provide effective treatments for chronic conditions. In addition to its ophthalmic pipeline, the company maintains assets in the field of mesenchymal stem cell therapies, including Progenza, which targets osteoarthritis and neuropathic pain. The company emphasizes a data-driven approach to clinical development, seeking to improve patient outcomes through advanced tissue engineering and cell-based solutions.

Recent filings

Filing Released Lang Actions
Annual Report 2019 53 pages 1.2MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2019 Regeneus Ltd' and contains detailed sections typical of an annual report, including a letter from the Chairman and CEO, Directors' report, consolidated financial statements (profit or loss, financial position, changes in equity, cash flows), notes to the financial statements, directors' declaration, and an independent auditor's report. It covers the full fiscal year ended 30 June 2019 and includes comprehensive financial and operational information. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2019
2019-10-29 English
Appendix 4G and Corporate Governance Statement 18 pages 326.9KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance-related disclosure that accompanies the annual report but is not the annual report itself. The document discusses compliance with corporate governance principles and provides a key to where governance disclosures can be found, including URLs to the corporate governance statement on the company's website. It is a regulatory filing required to be lodged with the ASX alongside the annual report but does not contain financial statements or detailed financial performance data. The document is about corporate governance disclosures and compliance with governance recommendations, which aligns with Governance Information filings. It is not an Annual Report (10-K), nor an Audit Report, nor a Management Report. It is not a report publication announcement since it contains substantive governance disclosure content rather than just announcing a report's availability. Therefore, the best classification is Governance Information (CGR). Confidence is high given the clear references to governance principles and ASX corporate governance rules.
2019-10-29 English
Notice of Annual General Meeting / Proxy Form 21 pages 415.1KB
AGM Information Classification · 95% confidence The document is titled 'Notice of Annual General Meeting 21 November 2019 and Explanatory Statement' and contains detailed information about the AGM including date, location, resolutions to be voted on, voting procedures, and explanatory notes for each resolution. It includes items such as adoption of the remuneration report, re-election of directors, approval of share option plans, and ratification of share issues. The document is clearly a notice and explanatory statement for an upcoming Annual General Meeting, not the actual meeting minutes or financial reports themselves. It is not a full annual report, audit report, or earnings release. The content matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length (15,000 characters) and detailed agenda support this classification with high confidence.
2019-10-17 English
Change of Registered Office and Principal Place of Business 1
Regulatory Filings Classification · 95% confidence The document is a brief announcement dated 15 October 2019 from Regeneus Limited to ASX Ltd regarding a change in the company's registered office and principal place of business. It contains no financial data, no report content, and is very short (477 characters). It is not a report or detailed filing but a regulatory announcement about a corporate administrative change. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-10-14 English
Regeneus receives A$1.5 million in R&D Tax Incentives 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 15 October 2019 regarding Regeneus Ltd receiving A$1.5 million in R&D Tax Incentives for FY19. It discusses the use of these funds to repay loans and reduce borrowings, focusing on capital management. The content is a brief update on financing and capital structure changes rather than a full financial report or detailed financial statements. The document length is short (1589 characters), and it is clearly an announcement of a financing-related event. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-10-14 English
Financial Report - Year Ended 30 June 2019 52 pages 691.5KB
Annual Report Classification · 100% confidence The document is titled 'Financial Report – Year Ended 30 June 2019' and contains detailed financial statements, including Directors' Report, Auditor's independence declaration, consolidated statements of profit or loss, financial position, changes in equity, cash flows, notes to the financial statements, Directors' declaration, and Independent auditor's report. It covers the full fiscal year ended 30 June 2019, includes operational and financial reviews, and detailed financial data. The length is substantial (15,000 characters), indicating it is the full report, not just an announcement or summary. The presence of comprehensive financial statements and management discussion confirms this is an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2019
2019-09-25 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.